@article{Oerlemans_2021,
title={Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics},
volume={12},
ISSN={2632-8682},
url={http://dx.doi.org/10.1039/d0md00367k},
DOI={10.1039/d0md00367k},
number={3},
journal={RSC Medicinal Chemistry},
publisher={Royal Society of Chemistry (RSC)},
author={Oerlemans,
Rick and Ruiz-Moreno,
Angel Jonathan and Cong,
Yingying and Dinesh Kumar,
Nilima and Velasco-Velazquez,
Marco A. and Neochoritis,
Constantinos G. and Smith,
Jolanda and Reggiori,
Fulvio and Groves,
Matthew R. and Dömling,
Alexander},
year={2021},
pages={370–379} }